$GBUX Balance Sheet | Understand Stock

$GBUX

$0.00 -$0.00 (11.11%) Close

Financial Statements

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024
Cash
Prepaid expenses
Other receivable
Deferred offering costs
Total current assets
Operating lease right of use asset
Property and equipment, net
Total Assets
Current Liabilities
Accounts payable
Accrued liabilities
Advances for convertible note to be issued
Accounts payable and accrued liabilities
Advances for convertible notes to be issued
Due to related party
Related Party
Total due to related party
Notes payable - related parties
Related Party
Total notes payable - related parties
Loans payable, net discount of $0
Convertible notes, net discount of $253,000 and $121,464
Derivative liabilities
Total Current Liabilities
Total Liabilities
Stockholders' Deficit
Preferred stock: 10,000,000 authorized; $0.001 par value 1,000,000 and 0 shares of Series C Preferred Stock issued and outstanding, respectively
Common stock: 3,490,000,000 authorized; $0.001 par value 174,150,989 and 99,061,523 shares issued and outstanding, respectively
Additional paid in capital
Common stock to be issued, 46,667 shares
Common stock to be issued, 15,046,667 shares
Collateral stock, at par value: 2,775,000 shares
Accumulated deficit
Total Stockholders' Deficit
Total Liabilities and Stockholders' Deficit

Comments